Icon
+91 94997 68112
Login Register

Protonix IV - (EQ 40MG BASE/VIAL; Injectable)

Pantoprazole Sodium Wyeth Pharma
EQ 40MG BASE/VIAL; Injectable
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
Less Than 5
More Than 5
More Than 5
Indicated for short-term treatment (7 to 10 days) of adult patients with gastroesophageal reflux disease (GERD) and a history of erosive esophagitis.
Yes
*** ****** *** ***** ** **** **** ** *** ********** ******* ** ******** *** ******* *******-**** **, **** & *******-*** **, ****. *** ***** * ****** *** *********** ********* ******** ********** & ***-************ ** '*** ****** ** *** *************. ***** ***** * ****** ** ******* ***'* ****** *** '*** ****** ***** *** ******** ** *** *****. *** ********** *** '*** ****** *** ********* ** *** ******* ** "**** ** ***********". **** ***** *** *** ******* ****** ****** '*** ******* *** *** *** ** ******* ********* *** ****** **** *** ********** **** ***. ***** **** *** ***** ******* ********* ******, ******, **** (***** ***(*)*) **** ***** **** ** **** ****** '*** & **** ************ *********. ******* ****** *** ***** ***, *** *******'* *********** ******* ****** ******** ** ******* ***** *** *** *** ********* ******** ****** *** ********** ****** ** **-******. ********** ** ********* **** *** *** ********* ***** *** ***** ** ********* *** *** *****. **** ****** *** ******(*****) **** ******** *** ** ***** **** **** **** *** ******** *** ******* ** ***.
Protonix IV Patent 1 Patent 2 Patent 3 Patent 4
*** ****** ******* ******* ******* *******
****** ******* ******* ******* *******
****** ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
*** ****** *** \ ** ***, **** ******* ******** ******** ** *** *, ****
****** ** \ ** ****, **** ******* **** ****** **** ********
****** ** \ ** ***, **** ******* ******** ******** ** *** **, ****
  1. ****, **** : ***** & ****** (**** ***** ******* "*****" ******* ***** *** ******), ******** ************ **** *** ***** *** **** ** *** ******* '*** *** '***.
  2. ***, **** : ***** ***** **** ******* *** ** ******** ***** ** **.
  3. ***, **** : ***** ***** *** ********* *********, ** ***** ***** ******* *** ********** ******* ****** ** ****** '***.
  4. ****, **** : ***** ******* *****'* ******* *** ********* *** ************* ***** ** *** ***** ** ****** '***.
  5. ***, **** : ****** ******** ***** ***** *** **** ** ** ****** '***. (*) *** ****: ***** ***** ******* ******* ****** ** ******** ***** ** ********.
  6. *****, **** : ****** ******** ***** ***** *** **** ** ** ****** '***.
  7. ***, **** : ***** **** ****** ** ******** ***** ** ********.
  8. *****, **** : ***** ******** ************ **** **** ***** *** **** ** ***** ***(*)* ** ****** '***.
  9. ****, **** : ***** *** ******* ***** * ********** ******* **** ** ******** ***** ** *** ******.
  10. ***, **** : **** ******** ********* ********.
  11. *** **, **** : ********** *** ********* **** ****** ***** *** ***** ** ********* *** *** *****.
  12. *** *, **** : ********** *** ********* **** ****** ***** *** ***** ** ********* *** *** *****
  13. *** **, **** : ********** ********* **** ****
  14. *** **, **** : ********** ********* **** *** ******
  15. *** **, **** : ********* ******** ******* ************ ****** ** ** ********* ** **

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.